Evonik Industries AG
  • Evonik worldwide
Evonik Industries AG
  • Company
  • Products and Solutions
  • Responsibility
  • Investor Relations
  • Media
  • Career
  • Home
  • Company
  • Products and Solutions
  • Responsibility
  • Investor Relations
  • Media
  • Career

New lipid production facility in the U.S.

The new plant at Evonik’s Tippecanoe site in Lafayette, Indiana, will broadly position the Group for future growth in novel mRNA-based therapies beyond COVID-19 vaccines and strengthen its leading role as a strategic partner for innovative pharmaceutical companies worldwide. ... MORE

Health Care
Jul 05, 2022

Evonik launches non-animal-derived collagen platform Vecollan® at commercial scale for medical device applications

Evonik’s recombinant, non-animal-derived collagen platform is now available at commercial scale. Vecollan® is highly pure and soluble collagen that is produced via fermentation. ... MORE

Care Solutions
Jun 29, 2022

Evonik marks start of a revolution in cleaning and personal care with groundbreaking ceremony

Evonik is celebrating the start of construction of the world’s first commercial rhamnolipid production facility with a groundbreaking ceremony today. ... MORE

CALOSTAT®
Jun 10, 2022

CALOSTAT® wins German Brand Award 2022 in Gold

CALOSTAT®, Evonik’s brand of mineral-based, high-performance insulating material, has won gold in the “Excellent Brands: Building & Elements” category for this year’s German Brand Award.  ... MORE

Company
Jun 10, 2022

Evonik spends venture capital on sustainability funds Azolla Ventures and Chrysalix 

Evonik Venture Capital has invested in two sustainability funds: Azolla Ventures I and the Chrysalix Venture Capital’s Carbon Neutrality Fund. ... MORE

Health Care
Jun 07, 2022

Evonik launches new peptide to boost productivity of cell-culture-based biopharmaceuticals

The cell culture ingredient cQrex® AC, a chemically defined and highly soluble source of L-cystine, increases efficiency and productivity in bioprocesses for producing monoclonal antibodies, vaccines, viral vectors, and therapeutic cells. ... MORE

Health Care
Jun 02, 2022

Evonik invests US$220 million in partnership with the U.S. Government to build new lipid production facility for mRNA-based therapies in the U.S.

The new plant will broadly position the Group for future growth in mRNA-based therapies and strengthen its leading role as a strategic partner for pharmaceutical companies worldwide. ... MORE

Leading beyond chemistry

Evonik is on its way to becoming the world’s best specialty chemicals company. Today, we already play a leading role in our markets as well as in driving our industry’s development. ... MORE

Dishwashing with sugar

Biosurfactants that are produced by the fermentation of sugar are in demand for the manufacture of cosmetics and detergents. ... MORE

Products and solutions

Here you can find the information about our products, markets, industry teams and delivery conditions. We go beyond chemistry as we work with our customers to develop solutions that make products better. A ... MORE

Career

You want to know more about career paths at Evonik? Here you will find all information about Evonik as employer. ... MORE

Social Media

Here you can find our news on Social Media. As colorful and diverse as the world of Evonik are the Social Media Channels of the company. Follow us - on LinkedIn, Twitter, YouTube, Facebook, Instagram and TikTok. ... MORE

  • Contact
  • Company Information
  • Legal Notice
  • Privacy Policy
  • Sitemap